Concepedia

Maxwell M. Reeve

MM

Statistics

Publications

4

Citations

137

H-Index

4

Active since

1992

Affiliations

Melinta Therapeutics (United States)(Current)

Maxwell M. Reeve is an author at Melinta Therapeutics (United States) specializing in chemistry, enzyme inhibition, and hmg-coa reductase inhibitors.

Publications per year

1992–2010

4

Publications

4

Synthesis of an Antibacterial Compound Containing a 1,4-Substituted 1<i>H</i>-1,2,3-Triazole: A Scaleable Alternative to the “Click” Reaction

Roger Hanselmann, Gabriel E. Job, Graham Johnson et al. · Organic Process Research & Development · 2009 · 78 citations

, , +13

Total synthesis of dihydromevinolin and a series of related 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

Christopher M. Blackwell, Alan H. Davidson, Steven B. Launchbury et al. · The Journal of Organic Chemistry · 1992 · 30 citations

, , +9

An improved procedure for the introduction of the .delta.-lactone portion of HMG-CoA reductase inhibitors

Christopher M. Blackwell, Alan H. Davidson, Steven B. Launchbury et al. · The Journal of Organic Chemistry · 1992 · 18 citations

, , +6

Current Practices of Process Validation for Drug Substances and Intermediates

Neal G. Anderson, David C. Burdick, Maxwell M. Reeve · Organic Process Research & Development · 2010 · 11 citations

, , +17

1–4 of 4